CBX7 and cervical carcinoma: To determine whether overexpression of CBX7 governs cell proliferation in cervical cancer cells, the 3-(4,5-dimethylthiazol −2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to detect the proliferation of HeLa and Caski cells after CBX7 overexpression.